Organigram Holdings Inc. reported a net loss of $4 million for its fiscal fourth quarter ended September 30, 2024, translating to a loss of 4 cents per share. Despite the net loss, the company achieved a 22% year-over-year increase in revenue, indicating growth in its core operations.
The company highlighted strategic international expansions as a key development during this period, contributing to its revenue growth. These expansions are part of Organigram's broader strategy to diversify its market presence beyond Canada.
The financial results reflect the company's ongoing efforts to grow its business and improve its operational footprint, even as it navigates the complexities of the cannabis market. The reported revenue increase suggests positive momentum in sales despite the recorded net loss.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.